Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Manulife Financial Corporation (MFC) vs Rocket Lab USA Inc (RKLB) Price & Performance

Manulife Financial CorporationTrade
Rocket Lab USA IncTrade

Price performance (Past 24H)

Key statistics

Manulife Financial Corporation vs Rocket Lab USA Inc — how do they compare? Manulife Financial Corporation trades at $42.52 (market cap $69.48B), while Rocket Lab USA Inc trades at $68.58 (market cap $43.74B). The key difference: Manulife Financial Corporation is the larger of the two by market cap, and Manulife Financial Corporation pays a 3.23% dividend while Rocket Lab USA Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Manulife Financial Corporation for 119 Days and Rocket Lab USA Inc for 29 Days on average.

MFCRKLB
Market Cap
$69.48B$43.74B
Volume
1,347,50822,892,581
Sector
FinancialsIndustrials
52-Week High
$44.77$150.23
52-Week Low
$31.64$39.48
Typical Hold Time
119 Days29 Days
Enterprise Value
$64.75B$41.57B
Dividend Yield
3.23%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Manulife Financial Corporation

MFC trades at $42.33, up 1.58% today, with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth from $53.01B in 2025 to projected $57.5B in 2026, with net income margins around 11%. Recent institutional investments from Bank of America and executive appointments signal confidence. However, the stock trades above the $34.24 consensus price target, suggesting limited near-term upside.

The outlook remains mixed with solid fundamentals but valuation concerns. Investment opportunity lies in continued Asia growth and insurance sales momentum, while risks include premium valuation and potential earnings volatility. Analyst consensus leans bullish with 57% buy ratings, but technical indicators warn of near-term pressure.

Rocket Lab USA Inc

Rocket Lab (RKLB) trades at $68.35, down 4.96% in the last session, reflecting a bearish technical trend. The company's fundamentals show strong revenue growth, with 2026 revenue projected at $769 million, but it remains unprofitable with a net loss of -$165 million. Recent positive news includes securing its largest-ever commercial Electron launch deal with Synspective, boosting its backlog to over 100 missions. Analyst sentiment is predominantly bullish, with a consensus price target of $107.00.

The outlook for RKLB hinges on execution of its growing launch backlog and path to profitability. Investment opportunity lies in its leading position in small satellite launch services and expanding spacecraft business. Key risks include intense competition from SpaceX, high cash burn, and reliance on future Neutron rocket success. The stock offers high growth potential but carries significant execution and valuation risks.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MFC
100% Buy0% Sell
Avg holding period · 119 Days
RKLB
92% Buy8% Sell
Avg holding period · 29 Days

Top news

Latest headlines on both assets

About Manulife Financial Corporation

Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.

Read more on MFC →

About Rocket Lab USA Inc

Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.

Read more on RKLB →